Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 21:00:00 22/05/2024 BST 		5-day change 1st Jan Change
2.92 USD -2.99% Intraday chart for Revance Therapeutics, Inc. -11.78% -66.78%
05-10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
05-10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT
8a8013.Jc32tIvKFYxfgBHMKXNOOHEOSb7QdeNZgD2uJZKplJc.QvmAjPKiONpmt3OCYwMZQAVeCu-CPacosXzdYqaE0dscqMTf0oN7yT7Ucg~46df82286e34c8a05f9d6f4eeb771ff1
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. News Chart